Form 4: Twist Bioscience Grants SVP Paula Green 26,200 RSUs

Twist Bioscience Corp's SVP of Human Resources, Paula Green, was granted 26,200 restricted stock units, vesting quarterly over four years.

Summary

• Paula Green, SVP of Human Resources at Twist Bioscience Corp (TWST), was granted 26,200 shares of common stock.
• The transaction occurred on November 18, 2025, with the shares acquired as a Restricted Stock Unit (RSU) award at a price of $0 per share.
• Following this transaction, Paula Green beneficially owns a total of 168,387 shares of common stock.
• The RSU award vests over a 48-month period, with 1/16th of the total number of RSUs vesting on each quarterly anniversary of November 20, 2025.
• Vesting is contingent upon Paula Green's continuous service through each vesting date.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive as it reflects standard executive compensation practices aimed at retention and alignment of interests, without indicating any negative operational or financial news.

Positives

• The grant of Restricted Stock Units (RSUs) to a Senior Vice President aligns management's interests with long-term shareholder value.
• Equity compensation serves as a key retention tool for executive talent, ensuring continuity in leadership.

Negatives

• No specific negatives are detailed in this insider transaction report.

Risks

• No specific risks are detailed in this insider transaction report.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's financial performance or strategic outlook, focusing solely on an insider's equity transaction.

Industry Context

The granting of Restricted Stock Units (RSUs) is a standard practice in the biotechnology and life sciences industry for compensating and retaining key executives. This form of equity compensation is widely used to align executive incentives with long-term company performance and shareholder interests, common among publicly traded companies like Twist Bioscience.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) as a compensation mechanism for senior executives is a common practice across the technology and biotechnology sectors, including companies like Illumina, Pacific Biosciences, and Ginkgo Bioworks, which frequently utilize similar equity-based incentives.
• A four-year vesting schedule, with quarterly increments, is a typical structure for RSU awards, designed to promote long-term retention and performance alignment, consistent with industry benchmarks.

Stakeholder Impact

• Shareholders: Potential for minor future dilution as RSUs vest, but also improved executive retention and alignment with long-term company performance.
• Employees: Reinforces the company's commitment to equity-based compensation, potentially boosting morale and retention among other employees.

Next Steps

• The granted Restricted Stock Units will vest quarterly over the next 48 months, subject to continuous service.

Key Dates

Keywords

Twist Bioscience, TWST, Restricted Stock Units, RSU, Insider Transaction, Equity Compensation, Paula Green, SVP Human Resources, SEC Form 4